Clinical Trials: Non-Hodgkin’s Lymphoma
We currently have a pilot Phase II approved protocol for previously untreated Stage III or IV asymptomatic, non-bulky Follicular lymphoma, ready for execution and are designing additional protocols for FL utilizing total antigenic repertoire as well as novel neo-antigens.
Proposed Principal Investigator:
Proposed PI: Dr. Sattva Neelapu, M.D., Anderson Cancer Center, TX, IND # 15639
Status: Active, Not recruiting patients